Risk of repeat biopsy and prostate cancer detection after an initial extended negative biopsy: longitudinal follow-up from a prospective trial-Reference-Cited by-同舟云学术

Risk of repeat biopsy and prostate cancer detection after an initial extended negative biopsy: longitudinal follow-up from a prospective trial

Published:2013-03-04 Issue:6 Volume:111 Page:988-996
ISSN:1464-4096
Container-title:BJU International
language:en
Short-container-title:BJU Int

Author:

Ploussard Guillaume¹,Nicolaiew Nathalie¹,Marchand Charles¹,Terry Stéphane¹,Allory Yves¹,Vacherot Francis¹,Abbou Claude-Clément¹,Salomon Laurent¹,de la Taille Alexandre¹

Affiliation:

1. Departments of Urology and Pathology; Assistance Publique-Hôpitaux de Paris; CHU Henri Mondor; Créteil France

Publisher

Wiley

Subject

Urology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/j.1464-410X.2012.11607.x/fullpdf

Reference23 articles.

1. The optimal rebiopsy prostatic scheme depends on patient clinical characteristics: results of a recursive partitioning analysis based on a 24-core systematic scheme;Scattoni;Eur Urol,2011

2. Prostate cancer detection rate in patients with repeated extended 21-sample needle biopsy;Campos-Fernandes;Eur Urol,2009

3. Risk factors for prostate cancer detection after a negative biopsy: a novel multivariable longitudinal approach;Gann;J Clin Oncol,2010

4. A nomogram for predicting a positive repeat prostate biopsy in patients with a previous negative biopsy session;Lopez-Corona;J Urol,2003

5. Development and external validation of an extended repeat biopsy nomogram;Chun;J Urol,2007

Cited by 59 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Clinical utility of transperineal template-guided mapping prostate biopsy in a selection of patients under active surveillance and confirmation of patients with negative biopsy for prostate cancer;2024-04-29

2. The role of inflammatory processes and zinc levels in prostatic enlargement among Iraqi samples;Journal of Medicine and Life;2023-09

3. ACR Appropriateness Criteria® Pretreatment Detection, Surveillance, and Staging of Prostate Cancer: 2022 Update;Journal of the American College of Radiology;2023-05

4. Neutrophil-to-lymphocyte and platelet-to-lymphocyte ratios alone or combined with prostate-specific antigen for the diagnosis of prostate cancer and clinically significant prostate cancer;Asian Journal of Urology;2023-04

5. Prospective study of prostate cancer detection using multiparametric magnetic resonance imaging ultrasound-guided fusion, standard, and saturation biopsy;Cancer Urology;2023-02-28